Literature DB >> 9738059

Plaque formation by and plaque cloning of Chlamydia trachomatis biovar trachoma.

A Matsumoto1, H Izutsu, N Miyashita, M Ohuchi.   

Abstract

A new technique for the induction of plaque formation by Chlamydia trachomatis biovar trachoma applicable to the titration of infectivity and cloning of biovar trachoma was established. Three novel strains were cloned and confirmed to be free of glycogen inclusions. The lack of glycogen accumulation correlated with the absence of a 7.5-kb plasmid, which is highly conserved in other strains of C. trachomatis. Although the growth efficiency of these plasmid-free strains was slightly lower than that of plasmid-positive strains, possession of the plasmid and glycogen accumulation were not essential for the survival of C. trachomatis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9738059      PMCID: PMC105103     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  39 in total

1.  PLAQUE FORMATION BY PSITTACOSIS VIRUS.

Authors:  E H KOZIKOWSKI; N HAHON
Journal:  J Bacteriol       Date:  1964-08       Impact factor: 3.490

2.  Biochemical changes in FL cell-cultures infected with a trachoma agent.

Authors:  Y BECKER; P MASHIAH; H BERNKOPF
Journal:  Nature       Date:  1962-01-20       Impact factor: 49.962

3.  Diversity of the Chlamydia trachomatis common plasmid in biovars with different pathogenicity.

Authors:  M Comanducci; S Ricci; R Cevenini; G Ratti
Journal:  Plasmid       Date:  1990-03       Impact factor: 3.466

4.  Electron microscopic visualization of DNA in association with cellular components.

Authors:  J D Griffith
Journal:  Methods Cell Biol       Date:  1973       Impact factor: 1.441

5.  Genetic diversity of avian and mammalian Chlamydia psittaci strains and relation to host origin.

Authors:  H Fukushi; K Hirai
Journal:  J Bacteriol       Date:  1989-05       Impact factor: 3.490

6.  Humoral immune response to plasmid protein pgp3 in patients with Chlamydia trachomatis infection.

Authors:  M Comanducci; R Manetti; L Bini; A Santucci; V Pallini; R Cevenini; J M Sueur; J Orfila; G Ratti
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Immunotyping of Chlamydia trachomatis with monoclonal antibodies.

Authors:  S P Wang; C C Kuo; R C Barnes; R S Stephens; J T Grayston
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

8.  The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism.

Authors:  E M Peterson; B A Markoff; J Schachter; L M de la Maza
Journal:  Plasmid       Date:  1990-03       Impact factor: 3.466

9.  Glycogen metabolism in Chlamydia-infected HeLa-cells.

Authors:  V S Fan; H M Jenkin
Journal:  J Bacteriol       Date:  1970-10       Impact factor: 3.490

10.  Amplification of Chlamydia trachomatis DNA by ligase chain reaction.

Authors:  B J Dille; C C Butzen; L G Birkenmeyer
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

View more
  61 in total

Review 1.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Tight binding of influenza virus hemagglutinin to its receptor interferes with fusion pore dilation.

Authors:  Masanobu Ohuchi; Reiko Ohuchi; Tatsuya Sakai; Akira Matsumoto
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Isolation of Chlamydia pneumoniae clonal variants by a focus-forming assay.

Authors:  Jens Gieffers; Robert J Belland; William Whitmire; Scot Ouellette; Deborah Crane; Matthias Maass; Gerald I Byrne; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

4.  Infectivity acts as in vivo selection for maintenance of the chlamydial cryptic plasmid.

Authors:  Marsha Russell; Toni Darville; Kumar Chandra-Kuntal; Bennett Smith; Charles W Andrews; Catherine M O'Connell
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

5.  Beyond Tryptophan Synthase: Identification of Genes That Contribute to Chlamydia trachomatis Survival during Gamma Interferon-Induced Persistence and Reactivation.

Authors:  Matthew K Muramatsu; Julie A Brothwell; Barry D Stein; Timothy E Putman; Daniel D Rockey; David E Nelson
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

6.  Development and validation of a rotor-gene real-time PCR assay for detection, identification, and quantification of Chlamydia trachomatis in a single reaction.

Authors:  Hamid Jalal; Hannah Stephen; Martin D Curran; Janet Burton; Michelle Bradley; Christopher Carne
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

7.  Efficient method of cloning the obligate intracellular bacterium Coxiella burnetii.

Authors:  Paul A Beare; Dale Howe; Diane C Cockrell; Robert A Heinzen
Journal:  Appl Environ Microbiol       Date:  2007-04-27       Impact factor: 4.792

8.  Chlamydia trachomatis ChxR is a transcriptional regulator of virulence factors that function in in vivo host-pathogen interactions.

Authors:  Chunfu Yang; Laszlo Kari; Gail L Sturdevant; Lihua Song; Michael John Patton; Claire E Couch; Jillian M Ilgenfritz; Timothy R Southern; William M Whitmire; Michael Briones; Christine Bonner; Chris Grant; Pinzhao Hu; Grant McClarty; Harlan D Caldwell
Journal:  Pathog Dis       Date:  2017-04-01       Impact factor: 3.166

9.  Plasmid-mediated transformation tropism of chlamydial biovars.

Authors:  Lihua Song; John H Carlson; Bing Zhou; Kimmo Virtaneva; William M Whitmire; Gail L Sturdevant; Stephen F Porcella; Grant McClarty; Harlan D Caldwell
Journal:  Pathog Dis       Date:  2013-11-11       Impact factor: 3.166

10.  The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor.

Authors:  John H Carlson; William M Whitmire; Deborah D Crane; Luke Wicke; Kimmo Virtaneva; Daniel E Sturdevant; John J Kupko; Stephen F Porcella; Neysha Martinez-Orengo; Robert A Heinzen; Laszlo Kari; Harlan D Caldwell
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.